Official websites use .gov
Secure .gov websites use HTTPS
Demonstrating return on investment for infection prevention and control
Demonstrating return on investment for infection prevention and control
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Pennsylvania patient safety advisory
- Contributor(s):
- Pennsylvania. Patient Safety Authority.
ECRI (Organization)
Institute for Safe Medication Practices. - Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Cost-Benefit Analysis
Cross Infection -- economics
Cross Infection -- prevention & control
Infection Control -- economics
United States - Genre(s):
- Technical Report
- Abstract:
- Healthcare-associated infections (HAIs) represent 4.5 infections for every 100 hospital admissions and account for an estimated 99,000 deaths in the United States each year. In 2007, the Pennsylvania Health Care Cost Containment Council reported hospital charges of $35,168 in cases without an HAI to $191,872 in cases with an HAI, with a difference of 15.3 days in the average length of stay. Effective infection prevention and control programs demonstrate a valuable return on investment by releasing hospital resources for alternative uses and beds for new admissions. The Centers for Disease Control and Prevention estimates that the $45 billion annual direct cost of HAIs could be significantly reduced by as much as $31.5 billion with well resourced, quality infection prevention and control programs. Organizations may have inadequate methods to investigate the true cost of HAIs or the cost-effectiveness of infection prevention and control program. This article provides practical methods to engage healthcare executives in evaluating the cost of HAIs in their organization and to dispel common misperceptions about the significance of HAIs, reimbursement, and cost savings associated with effective HAI reduction programs. Using these methods will assist hospital epidemiologists to develop a compelling business case for infection prevention and control programs.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-DC license. (More information)
- NLM Unique ID:
- 101542987 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101542987